Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 674 | 743 | 810 | 853 | 763 |
| Gross Profit | 674 | 743 | 810 | 853 | 763 |
| Operating Expenses | 8,804 | 8,938 | 10,906 | 13,695 | 14,902 |
| Operating Income | -8,130 | -8,195 | -10,096 | -12,842 | -14,139 |
| Interest Expense | 0 | 0 | 0 | -227 | 304 |
| Other Income | 250 | 561 | -77 | 0 | 0 |
| Pre-tax Income | -7,880 | -7,634 | -10,173 | -12,615 | -14,443 |
| Net Income Continuous | -7,880 | -7,634 | -10,173 | -12,615 | -14,443 |
| Net Income | $-7,880 | $-7,634 | $-10,173 | $-12,615 | $-14,443 |
| EPS Basic Total Ops | 0.00 | -3.00 | -3.00 | -9.00 | -12.00 |
| EPS Basic Continuous Ops | -1.09 | -1.79 | -3.74 | -6.84 | -12.09 |
| EPS Diluted Total Ops | 0.00 | -3.00 | -3.00 | -9.00 | -12.00 |
| EPS Diluted Continuous Ops | -1.09 | -1.79 | -3.74 | -6.84 | -12.09 |
| EPS Diluted Before Non-Recurring Items | -1.09 | -1.79 | -3.74 | -6.80 | -12.00 |
| EBITDA(a) | $-8,123 | $-8,180 | $-10,082 | $-12,828 | $-14,127 |